Skip to main content
Premium Trial:

Request an Annual Quote

Recent Lay-offs at Proteome Systems Will Cut Costs 30 Percent

NEW YORK, Nov. 22 (GenomeWeb News) - Proteome Systems has implemented a cost-management program that is to include job cuts in its Boston and Sydney, Australia, facilities.


The exact number of jobs that will be eliminated was not immediately clear.


According to the company, the reduction in headcount, along with a decrease in space requirements, is expected to lower monthly operating costs by 30 percent and result in an annualized savings of AU$6 million ($4.7 million) once they are fully implemented early next year.


Proteome Systems also noted that John Martin, executive director of the company, is stepping down from his position. The company noted that Martin will remain a non-executive director and consultant for at least the remainder of the financial year.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.